MannKind

MannKind: Trader Says This Drug Firm Will Snap Up 50% By Mid-2010
MannKind: Trader Says This Drug Firm Will Snap Up 50% By Mid-2010
CNBC
MannKind
Flag link:
Why I'm Taking a Foothold in Generex Now
Why I'm Taking a Foothold in Generex Now
Seeking Alpha
Generex
MannKind
Invo Bioscience
NovaDel
Flag link:
Drugmaker MannKind Chooses Lone Wolf Strategy
Drugmaker MannKind Chooses Lone Wolf Strategy
ethioPlanet
MannKind
diabetes
inhaled insulin
Afresa
Flag link:
MannKind Slides on News
MannKind Slides on News
Yahoo/Zacks
MannKind
Flag link:
Mannkind tanks, Acadia rallies
Mannkind tanks, Acadia rallies
Marketwatch
Acadia
MannKind
Afresa
pimavanserin
Flag link:
Fortunes Being Made in Small-Cap Pharmaceutical Stocks
Fortunes Being Made in Small-Cap Pharmaceutical Stocks
Yahoo/Indie Research
Neuralstem
Depomed
MannKind
AVI BioPharma
Osiris Therapeutics
Opexa
Flag link:
Analyst Lists Five Biotech Companies to Watch
Analyst Lists Five Biotech Companies to Watch
Patent Docs
Poniard
GTx
OncoGenex
MannKind
Rigel
Flag link:
On the Radar: Five biotech companies to watch
On the Radar: Five biotech companies to watch
Fierce Biotech
Rigel
Poniard
OncoGenex
MannKind
GTx
biotech
Flag link:
Biotech Discounts Galore
Biotech Discounts Galore
Seeking Alpha
biotech
RXi Pharmaceuticals
Ariad Pharmaceuticals
Human Genome Sciences
Inspire
MannKind
MAP Pharmaceuticals
Opexa
Transcept
Anesiva
Indenix
Flag link:
Will MannKind Bounce Back?
Will MannKind Bounce Back?
Yahoo/Zacks.com
MannKind
Flag link:
MannKind Closes Acquisition of Insulin Assets from Pfizer
MannKind Closes Acquisition of Insulin Assets from Pfizer
Yahoo
MannKind
insulin
diabetes
Pfizer
Afresa
Flag link:
MannKind Needs More Leaps
MannKind Needs More Leaps
Motley Fool
MannKind
inhaled insulin
Flag link:
[video]Giant Leap for Mannkind
[video]Giant Leap for Mannkind
CNBC
MannKind
inhaled insulin
diabetes
Flag link:
AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
Yahoo/PR Newswire
MannKind
Afresa
diabetes
Flag link:
FDA Accepts MannKind's Submission and Files NDA for AFRESA
FDA Accepts MannKind's Submission and Files NDA for AFRESA
Yahoo
FDA
MannKind
diabetes
Afresa
Flag link:
MannKind to acquire insulin facility from Pfizer
MannKind to acquire insulin facility from Pfizer
Marketwatch
insulin
Pfizer
MannKind
Flag link:
MannKind Remains in Peril
MannKind Remains in Peril
Yahoo/Zacks.com
MannKind
Novo Nordisk
Afresa
diabetes
inhaled insulin
insulin
Flag link:

Pages